The Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article

Bivalirudin is a direct thrombin inhibitor used during percutaneous coronary intervention (PCI). Treatment with bivalirudin compared to heparin plus glycoprotein IIb/IIIa inhibitors (GPI) reduced bleeding complications, but resulted in higher rates of ischemic events, including acute stent thrombosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreou, Constantinos, Maniotis, Christos, Koutouzis, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446815/
https://www.ncbi.nlm.nih.gov/pubmed/28105561
http://dx.doi.org/10.1007/s40119-017-0082-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446815/
https://www.ncbi.nlm.nih.gov/pubmed/28105561
http://dx.doi.org/10.1007/s40119-017-0082-x

Ejemplares similares